Tissue contrast is a major challenge in the application of computed tomography (CT) and micro-computed tomography (micro-CT) techniques for imaging cancer. Contrast medium is used in order to enhance contrast of certain organs of interest, as well as tumors. Several types of contrast media have been used to assess tumor vasculature, perfusion and angiogenesis in preclinical studies. In general, low molecular weight contrast media have been used to characterize the first pass vascular dynamics of tumors with fast CT systems, while blood pool agents have been preferred to explore the delayed vascular dynamics with micro-CT systems. Together, these approaches provide qualitative, semi-quantitative, and quantitative information of the vascular architecture and vascular functionality of tumors in the preclinical scenario. Herein, we present an overview of contrast media, imaging techniques, image analysis methods, and quantitative parameters that have been used to evaluate tumor angiogenesis in vivo in recent preclinical studies. Preclinical applications on lesion detection and characterization, evaluation of vascular parameters as prognostic and predictive biomarkers, and evaluation of treatment response are also reviewed. These applications have demonstrated the potential of contrast-enhanced x-ray imaging to provide, in a noninvasive manner, a landscape of the spatial and temporal heterogeneity of the angiogenic process underlying tumor development.
Contrast-enhanced digital subtraction (CEDS) imaging refers to radiological techniques based on the use of a contrast medium (generally iodinated) to increase the contrast between organs of interest and background anatomy in medical images. In this work, a commercial microCT (voltage range 30-45 kV, not specifically designed for quantitative studies) was characterized for use in preclinical CEDS quantitative studies. The characterization of the system consisted of quantifying and optimizing the performance of the X-ray tube and detector. The optimization was done on 2D images. A protocol to acquire original images (pre-subtraction) based on the characterization was established. The protocol faced the detector limitations, such as lack of stability of the response and non-uniformity in images of homogeneous objects. Radiological techniques (voltage and additional filtering) for studies with CEDS were optimized. Single energy temporal (SET) and dual energy (DE) subtractions modalities were studied. The optimization was done via subtracted images of calibrated iodine phantoms. The optimal technique was defined as the one that maximized a figure of merit given by the ratio of an image quality parameter (the square of the contrast to noise ratio) to the dose delivered. Dose was obtained using TLD-100 and TLD-300 thermoluminescent dosimeters and dose to water was evaluated inside a 2 cm thick acrylic phantom. The energy dependence of the TLD-100 response was estimated to be a function of the beam effective energy measured with TLD-300. After applying the protocol, it was possible to obtain subtracted images whose mean pixel value was a linear function of the iodine concentration in the object. Application of the protocol reduced the detector spatial and temporal variations down to ±10% and 3.7%, respectively. For SET subtraction, the optimal technique was 45 kV; for this, the measured beam effective energy at the central point inside the phantom was 20.2 ± 1.6 keV. For DE, 30 kV and 45 kV + 0.025 mm Mo (external filtering) was the optimal combination, and the measured beam effective energies were 20.0 ± 2.2 keV and 27.4 ± 3.0, respectively. Dose to water in SET and DE were 29 ± 5 and 14 ± 2 mGy, respectively. We have provided a standardized method to be used in the CEDS studies.
Dual-energy (DE) for quantitative material discrimination has emerged as a promising application of microCT to increase contrast discrimination in preclinical studies. Here we present a protocol designed to optimize DE image subtraction for contrast enhanced studies in rodents, employing iodine-based contrast medium (CM). Our investigation used an Albira ARS commercial unit, not specifically designed for quantitative CT tasks. DE subtraction was divided into stages that were independently analyzed: acquisition, volume reconstruction, image registration and image weighting. The DE radiological techniques (low- and high- energy) had been previously optimized to enhance the visualization of iodine-based CM. An independent reconstruction was needed to guarantee linearity between iodine intensity and its concentration for high energy acquisition; it also reduced structured noise occasionally produced by the microCT reconstruction software over uniform regions and improved bone visualization. Image registration was optimized combining an affine transformation with a non-linear transformation determined with the Free-Form Deformation algorithm. Two subtraction weight factors were determined: one that maximized the contrast-to-noise ratio (CNR) of iodine mixed with soft-tissue-equivalent resin and another that minimized CNR between bone-like rods and soft-tissue-equivalent material. A pilot test of the optimized protocol was performed on a rat injected with a continuous flow of CM.
The aim of this work was to systematically obtain quantitative imaging parameters with static and dynamic contrast-enhanced (CE) X-ray imaging techniques and to evaluate their correlation with histological biomarkers of angiogenesis in a subcutaneous C6 glioma model. Enhancement (E), iodine concentration (CI), and relative blood volume (rBV) were quantified from single- and dual-energy (SE and DE, respectively) micro-computed tomography (micro-CT) images, while rBV and volume transfer constant (Ktrans) were quantified from dynamic contrast-enhanced (DCE) planar images. CI and rBV allowed a better discernment of tumor regions from muscle than E in SE and DE images, while no significant differences were found for rBV and Ktrans in DCE images. An agreement was found in rBV for muscle quantified with the different imaging protocols, and in CI and E quantified with SE and DE protocols. Significant strong correlations (Pearson r > 0.7, p < 0.05) were found between a set of imaging parameters in SE images and histological biomarkers: E and CI in tumor periphery were associated with microvessel density (MVD) and necrosis, E and CI in the complete tumor with MVD, and rBV in the tumor periphery with MVD. In conclusion, quantitative imaging parameters obtained in SE micro-CT images could be used to characterize angiogenesis and necrosis in the subcutaneous C6 glioma model.